http://jcps.bjmu.edu.cn

• Full Papers • Previous Articles     Next Articles

A simulation study of sampling time point designing for therapeutic drug monitoring based on a population pharmacokinetic model

Yang Zhang, Ying Zhou, Xiang-Lin Zhang, Xiao Liu, Yi-Min Cui, Wei Lu*

  

  1. 1. Department of Pharmaceutics, School of Pharmaceutical Science, Peking University, Beijing 100083, China;
    2. The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100083, China;
    3. Department of Pharmacy, First Hospital, Peking University, Beijing 100034, China;
    4. China-Japan Friendship Hospital, Beijing 100029, China
  • Received:2007-05-16 Revised:2007-11-10 Online:2007-12-15 Published:2007-12-15
  • Contact: Wei Lu*

Abstract:

Aim To develop a method to estimate population pharmacokinetic parameters with the limited sampling time points provided clinically during therapeutic drug monitoring. Methods Various simulations were attempted using a one-compartment open model with the first order absorption to determine PK parameter estimates with different sampling strategies as a validation of the method. The estimated parameters were further verified by comparing to the observed values. Results The samples collected at the single time point close to the non-informative sampling time point designed by this method led to bias and inaccurate parameter estimations. Furthermore, the relationship between the estimated non-informative sampling time points and the values of the parameter was examined. The non-informative sampling time points have been developed under some typical occasions and the results were plotted to show the tendency. As a result, one non-informative time point was demonstrated to be appropriate for clearance and two for both volume of distribution and constant of absorption in the present study. It was found that the estimates of the non-informative sampling time points developed in the method increase with increases of volume of distribution and the decrease of clearance and constant of absorption. Conclusion A rational sampling strategy during therapeutic drug monitoring can be established using the method present in the study.

Key words: Therapeutic drug monitoring, Therapeutic drug monitoring, Sampling strategy, Sampling strategy, Non-informative time point, Non-informative time point, Population pharmacokinetics, Population pharmacokinetics

Supporting: